TikaMobile Launches Agentic AI-Native CRM Platform for Commercial Sales Teams

Outcome-Driven Intelligence Replaces Activity-Based Metrics, Powered by an Embedded AI That Acts on Live CRM Data

NEW YORK, May 4, 2026 — TikaMobile, a leading provider of intelligent digital solutions for life sciences, today unveiled TikaPharma, an AI-native CRM platform purpose-built for commercial pharma sales teams. TikaPharma moves commercial organizations beyond legacy “reach and frequency” reporting to outcome-driven intelligence that connects every rep interaction to prescription impact and revenue. It can be deployed as a standalone Commercial CRM or layered on top of an existing system without rip-and-replace.

Commercial pharma teams are under pressure to demonstrate measurable ROI on every field interaction, yet most CRMs still count activities instead of measuring what those activities produce.

TikaPharma changes that through agentic AI capabilities embedded across the sales execution cycle:

• An AI Assistant That Acts, Not Just Answers: Reps and sales leaders query the CRM in plain English and receive grounded answers in seconds — top targets by prescription decline, an HCP’s next best action, or a territory business review generated on demand. The assistant reasons over live CRM data and produces ready-to-share reports.
• TikaScore — Dynamic HCP Prioritization: TikaScore replaces static tier assignments with a real-time composite score for every HCP in a territory, weighing configurable signals across prescribing momentum, engagement recency, payer favorability, and call-plan gaps. The Next Best Action engine turns the score into specific guidance, and “Plan My Day” sequences the highest-impact HCPs by score, urgency, and geography. Average pre-call planning time drops from 20 minutes to 2 minutes per HCP.
• Smart Alerts for Sales Leadership: District Managers, Regional Business Directors, and VPs receive a prioritized weekly digest of execution gaps — flagging unseen target HCPs, territory NRx decline, and call-plan attainment risk before they show up in lagging indicators. Every threshold is tenant-configurable.

“Commercial teams have been measured on the wrong things for far too long,” said Manish Sharma, CEO of TikaMobile. “Counting calls and emails tells you nothing about whether you moved a prescription. TikaPharma replaces those vanity metrics with outcome intelligence — the rep gets one number to answer ‘who do I see today and what do I say,’ and our agentic AI does the rest: reasons over live data, writes the reports, and surfaces the next best action.”

TikaPharma is delivered through a configurable multi-tenant SaaS architecture and is part of a unified product suite alongside TikaMSL for Medical Affairs, TikaVEO for Medical Affairs Market Access, and TikaPayor for Commercial Market Access.

About TikaMobile

TikaMobile provides intelligent digital solutions for life sciences organizations, specializing in CRM and business intelligence platforms for commercial and medical affairs teams. With more than 10 years in life sciences, 5,000+ users served, and 94% platform utilization, TikaMobile’s product suite empowers field, medical, and market access teams to optimize HCP engagement, streamline workflows, and leverage agentic AI across diverse therapeutic areas. Learn more at Tikamobile.com.